Cenk Sumen
Equibles does not estimate personal net worth.
About Cenk Sumen
Maxcyte, Inc. reported in an 8-K filed January 26, 2024 that Cenk Sumen was terminated as Chief Scientific Officer, effective January 23, 2024.
“On January 23, 2024, Cenk Sumen, Ph.D.'s employment as Chief Scientific Officer of MaxCyte, Inc. (the "Company"), ended.”
Affiliation history
-
Maxcyte, Inc. (MXCT)
Proxy statement
Start not stated–2024-01-23